MTSR (Metsera, Inc.) Earnings per share for the last four quarters

Metsera Corp (MTSR) - corporate logo

Metsera Inc capitalization relies on the commercialization of innovative peptides for obesity treatment. The current YoY ttm net income per share growth on this GURU.Markets platform chart reflects price action where the 0.00 indicator expresses the state of the metric. Partnerships with research centers and manufacturing plants are accelerating business development, while a stable operating environment is ensured by minimal geopolitical influence.

MTSR metsera.com Net earnings per share (EPS TTM) (11/23/2025 - 11/29/2025)

MTSR (Metsera Corp): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Price metsera.com|MTSR - Consensus Target
- business market valuation indicators:
Market Value Metsera, Inc.|MTSR - Enterprise Value
- business book valuation details:
Book Value per Share Metsera|MTSR - Book Capitalization|Market Value to Book Value Ratio metsera.com|MTSR - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Capital Metsera Inc|MTSR - Long-Term Debt to Equity|Short-Term Debt to Equity Metsera Therapeutics|MTSR - Company Aggregate Debts|Debts to Net Assets Metsera, Inc.|MTSR - Company Long-Term Debt|Short-Term Debt Volume Metsera|Quick Liquidity Indicator metsera.com
- earnings and multiples data:
MTSR - Company Net Income|Future Profit Metsera Inc|MTSR - P/E Multiple|Projected Price to Earnings Ratio Metsera, Inc.|MTSR - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Metsera, Inc.|MTSR - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Metsera|MTSR - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months metsera.com|MTSR - Earnings per share growth in current year|Expected earnings per share trend next year Metsera Inc
Fundamental company valuation:MTSR (metsera.com)
Core merchandise of Metsera Therapeutics

This indicator measures the annual growth of net income per share over the last twelve months, reflecting the scaling speed of business profitability. Analyzing the current EPS YoY TTM growth rate allows for stress-testing the capital resilience of Metsera Inc. (MTSR) against Fed rates, assessing the ability of innovative obesity drugs to generate profit in a high-cost borrowing environment.

Competitor analysis

Net earnings per one share for the last twelve months ascendispharma.com|MDGL (Madrigal Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|CORT: Earnings per share for the last four quarters|RYTM (Rhythm Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Akero Corp|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (crinetics.com)|Earnings per share for the last twelve months NewAmsterdam Pharma Company N.V. NAMS|Soleno Therapeutics Inc (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx|Rezolute Inc (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Lexicon Pharma (LXRX)|Net earnings per share for the last 12 months MBX Corp MBX|Earnings per share for the last twelve months Altimmune, Inc. ALT|AARD - Net earnings per share for the last 12 months|Sagimet Biosciences Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months BioAge Labs|BMEA (Biomea) - Net earnings per share for the last 12 months|QNCX: Earnings per share for the last four quarters|Earnings per share for the last twelve months Fractyl Health, Inc.|vTv Therapeutics Inc (VTVT) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) ATPC|PLUR - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Synlogic SYBX|Earnings per share for the trailing year LPCN|Matinas BioPharma Holdings Inc. - Net earnings per share (EPS TTM)|SPRB - Net earnings per share (EPS TTM)|GLTO (Galecto) - Net earnings per share for the last 12 months|Carmell Corp. - Earnings per share for the trailing year|LUMO (Lumos Pharma Corp) - Net earnings per share (EPS TTM)|Organovo Corp (ONVO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Radius Recycling, Inc. (RDUS)